234 related articles for article (PubMed ID: 11684936)
21. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
22. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.
Katano H; Iwasaki T; Baba N; Terai M; Mori S; Iwamoto A; Kurata T; Sata T
J Virol; 2000 Apr; 74(8):3478-85. PubMed ID: 10729121
[TBL] [Abstract][Full Text] [Related]
23. Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?
Reinheimer C; Allwinn R; Stürmer M
Med Microbiol Immunol; 2011 Aug; 200(3):161-4. PubMed ID: 21336596
[TBL] [Abstract][Full Text] [Related]
24. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.
Kedes DH; Operskalski E; Busch M; Kohn R; Flood J; Ganem D
Nat Med; 1996 Aug; 2(8):918-24. PubMed ID: 8705863
[TBL] [Abstract][Full Text] [Related]
25. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
26. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma.
O'Brien TR; Kedes D; Ganem D; Macrae DR; Rosenberg PS; Molden J; Goedert JJ
J Infect Dis; 1999 Oct; 180(4):1010-7. PubMed ID: 10479125
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS.
Nawar E; Mbulaiteye SM; Gallant JE; Wohl DA; Ardini M; Hendershot T; Goedert JJ; Rabkin CS;
Int J Cancer; 2005 Jun; 115(2):296-300. PubMed ID: 15688390
[TBL] [Abstract][Full Text] [Related]
28. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
29. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
30. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland.
Regamey N; Cathomas G; Schwager M; Wernli M; Harr T; Erb P
J Clin Microbiol; 1998 Jun; 36(6):1784-6. PubMed ID: 9620422
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma in South Africa.
Sitas F; Newton R
J Natl Cancer Inst Monogr; 2001; (28):1-4. PubMed ID: 11158199
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
Mbulaiteye SM; Atkinson JO; Whitby D; Wohl DA; Gallant JE; Royal S; Goedert JJ; Rabkin CS
J Clin Virol; 2006 Apr; 35(4):442-9. PubMed ID: 16414306
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
35. HHV8 in renal transplant recipients.
Diociaiuti A; Nanni G; Cattani P; Lesnoni La Parola I; Masini C; Capuano M; Pozzetto U; Fadda G; Castagneto M; Cerimele D
Transpl Int; 2000; 13 Suppl 1():S410-2. PubMed ID: 11112044
[TBL] [Abstract][Full Text] [Related]
36. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
38. Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study.
Rezza G; Dorrucci M; Andreoni M; Arpino C; De Luca A; Monini P; Nicastri E; Alliegro MB; Pezzotti P; Ensoli B
Neurology; 1999 Dec; 53(9):2032-6. PubMed ID: 10599777
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
Labo N; Miley W; Benson CA; Campbell TB; Whitby D
AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
[TBL] [Abstract][Full Text] [Related]
40. High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population.
Plancoulaine S; Abel L; van Beveren M; Gessain A
J Natl Cancer Inst; 2002 Sep; 94(17):1333-5. PubMed ID: 12208899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
